Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency: A randomized double-blind trial

Chaim M. Roifman, Harry Schroeder, Melvin Berger, Ricardo Sorensen, Mark Ballow, Rebecca H. Buckley, Anita Gewurz, Phillip Korenblat, Gordon Sussman, Georg Lemm, Mark Stein, Donald Stark, Maria Louisa Ermitano, Anne Desroches, Bruce Mazer, Joseph Church, Zuhair Ballas, Alexandra Filipovich, Gilbert Friday, Donatella GraffinoMelvin Haysman, Alan Knutsen, Wendel Richmond, Arye Rubinstein, Frederick Marquinez, Don McNeil, Susanne Skoda-Smith

Research output: Contribution to journalArticle

104 Scopus citations

Fingerprint Dive into the research topics of 'Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency: A randomized double-blind trial'. Together they form a unique fingerprint.

Medicine & Life Sciences